Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low vs Standard Volume Levobupivacaine for Interscalene Block in Shoulder Surgery
NCT04385966Phase 3Completed
- Sponsor
- IIS Aragón
- Start
- Feb 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levobupivacaine in postoperative pain, sponsored by IIS Aragón. Primary endpoint: Change from Baseline Diaphragmatic Thickness Ratio at 4 hours. Started Feb 2020; status: completed.
02
Drugs
levobupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04385966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04385966.